Evaluation of mycotoxins, mycobiota, and toxigenic fungi in selected medicinal plants of Khyber Pakhtunkhwa, Pakistan

Fungal Biology

Volumn 118, Issue 9, 2014, Pages 776-784

  Ahmad, Bashir ^a   Ashiq, Samina ^a   Hussain, Arshad ^b   Bashir, Shumaila ^a   Hussain, Mubbashir ^c  

^a UNIVERSITY OF PESHAWAR   (Pakistan)

^b PCSIR LABORATORIES COMPLEX   (Pakistan)

^c KOHAT UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Pakistan)

Author keywords

AF; Aflatoxins; Fr; Herbal medicine; KP; Moulds; Ochratoxin A; OTA; Peshawar; RD

Indexed keywords

CROP DAMAGE; FUNGAL DISEASE; MEDICINAL PLANT; MYCOPARASITE; RISK FACTOR; TOXIN;

KHYBER-PAKHTUNKHWA; PAKISTAN;

ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; ASPERGILLUS PARASITICUS; FUNGI; GLYCYRRHIZA; MYCOTA; PAPAVER SOMNIFERUM; PENICILLIUM; WITHANIA COAGULANS;

MYCOTOXIN;

CHEMISTRY; CLASSIFICATION; FUNGUS; ISOLATION AND PURIFICATION; MEDICINAL PLANT; MICROBIOLOGY; PAKISTAN;

FUNGI; MYCOTOXINS; PAKISTAN; PLANTS, MEDICINAL;

EID: 84925956393     PISSN: 18786146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.funbio.2014.06.002     Document Type: Article

References (60)

1. Abdullah S.K., Al-Mriayne M.S., Al-Saadoon A.H. Mycobiota and incidence of aflatoxigenic Aspergillus section flavi in three medicinal plants in Iraq. Journal of University of Duhok 2009, 12:262-267.
2. Abou Donia M.A. Microbiological quality and aflatoxinogenesis of Egyptian spices and medicinal plants. Global Veterinaria 2008, 2:175-181.
3. Abou-Arab A.A.K., Kawther M.S., El Tantawy M.E., Badeaa R.I., Khayria N. Quantity estimation of some contaminants in commonly used medicinal plants in the Egyptian market. Food Chemistry 1999, 67:357-363.
4. Akram M., Shahab-uddin Ahmed A., Usmanghani K., Hannan A., Mohiuddin E., Asif M., Shah S.M.A. Glycyrrhiza glabra L. (medicinal uses). Journal of Medicinal Plants Research 2011, 5:5658-5661.
5. Andrews W. FAO, Manual of Food quality Control 4. Rev. 1. Microbiological Analysis 1992, Food and Drug Administration, WA D.C., USA.
6. AOAC Official Methods of Analysis 2005, Association of Official Analytical Chemists, WA D.C., USA. 18th edn.
7. Arayne M.S., Sultana N., Bahadur S.S. The Berberis story: Berberis vulgaris in therapeutics. Pakistan Journal of Pharmaceutical Sciences 2007, 20:83-92.
8. Arino A., Herrera M., Estopanan G., Juan T. High levels of ochratoxin A in licorice and derived products. International Journal of Food Microbiology 2007, 114:366-369.
9. Ashiq S., Hussain M., Ahmad B. Natural occurrence of mycotoxins in medicinal plants: a review. Fungal Genetics and Biology 2014, 66:1-10. http://dx.doi.org/10.1016/j.fgb.2014.02.005.
10. Biligrami K.S., Choudhry A.K. Impact of habitats on toxigenic potential of Aspergillus flavus. Journal of Stored Products Research 1993, 29:351-355.
11. Bugno A., Almodovar A.B., Pereira T.C., Pinto T.J.A., Sabino M. Occurrence of toxigenic fungi in herbal drugs. Brazilian Journal of Microbiology 2006, 37:47-51.
12. Calixto J.B. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Brazilian Journal of Medical and Biological Research 2000, 33:179-189.
13. Cowan M.M. Plant products as antimicrobial agents. Clinical Microbiology Reviews 1999, 12:564-582.
14. Dilokpimol A. Molds and Aflatoxin in Thai Curry Pastes and Their Spices 2003, M. Sc. Biotechnology thesis (2001-2003), Chulalongkorn University, Thailand.
15. Duke J.A. Medicinal plants and the pharmaceutical industry. New Crops: proceedings of the second national symposium new crops; exploration, research, commercialization 1993, 664-669. Wiley, New York. J. Janick, J.E. Simon (Eds.).
16. Efuntoye M.O. Mycotoxins of fungal strains from stored herbal plants and mycotoxin contents of Nigerian crude herbal drugs. Mycopathologia 1999, 147:43-48.
17. Elshafie A.E., Al-Rashdi T.A., Al-Bahry S.N., Bakheit C.S. Fungi and aflatoxins associated with spices in the Sultanate of Oman. Mycopathologia 2002, 155:155-160.
18. EP (European Pharmacopoeia), 2011. Council of Europe. European Directorate for the Quality of Medicines (EDQM), 7th edn.
19. EU European Union Commission Regulation (EU) No. 105/2010 of 5 February 2010 amending Regulation (EC) No 1881/2006 setting maximum levels for certain contaminants in foodstuffs as regards ochratoxin A. Official Journal of the European Union L 2010, 35:7-8.
20. FAO (Food and Agriculture Organization of United Nations) Manual on the Application of the HACCP System in Mycotoxin Prevention and Control 2001, 73, FAO Food and Nutrition Paper, Rome.
21. Farnsworth N.R. The role of ethnopharmacology in drug development. Bioactive Compounds from Plants. Ciba Foundation Symposium 1990, vol. 154:2-11. Wiley, Chichester, UK.
22. Farnsworth N.R., Akerele O., Bingel A.S., Soejarto D.D., Guo Z.G. Medicinal plants in therapy. Bulletin of the World Health Organization 1985, 63:965-981.
23. Feugang J.M., Konarski P., Zou D., Stintzing F.C., Zou C. Nutritional and medicinal use of cactus pear (Opuntia spp.) cladodes and fruits. Frontiers in Bioscience 2006, 11:2574-2589.
24. Filtenborg O., Frisvad J.C., Svendsen J.A. Simple screening method for molds producing intracellular mycotoxins in pure cultures. Applied and Environmental Microbiology 1983, 45:581-585.
25. Fraga M.E., Curvello F., Gatti M.J., Cavaglieri L.R., Dalcero A.M., da Rocha Rosa C.A. Potential aflatoxin and ochratoxin A production by Aspergillus species in poultry feed processing. Veterinary Research Communications 2007, 31:343-353.
26. Gautam A.K., Sharma S., Bhadauria R. Detection of toxigenic fungi and mycotoxins in medicinally important powdered herbal drugs. Internet Journal of Microbiology 2009, 7. 10.5580/104b.
27. Gonzalez H.H.L., Resnik S.L., Boca R.T., Marasas W.F.O. Mycoflora of Argentinian corn harvested in the main production area in 1990. Mycopathologia 1995, 130:29-36.
28. Haas H.F. Papaver somniferum (opium poppy). Journal of Neurology, Neurosurgery & Psychiatry 1995, 58:402.
29. Hamayun M., Afzal S., Khan M.A. Ethnopharmacology, indigenous collection and preservation techniques of some frequently used medicinal plants of Utror and Gabral, District Swat, Pakistan. African Journal of Traditional, Complementary and Alternative Medicines 2006, 3:57-73.
30. Jahani M., Rezaei O.M., Khodadadi M., Alemzadeh E. A survey of fungal contamination associated with barberry (Berberis spp.) in Iran. American Journal of Plant Sciences 2013, 4:1594-1596. http://dx.doi.org/10.4236/ajps.2013.48192.
31. Kumar S., Shekhar M., Ali K.A., Sharma P. A rapid technique for detection of toxigenic and non-toxigenic strain of Aspergillus flavus from maize grain. Indian Phytopathology 2007, 1:31-34.
32. Lisker N., Michaeli R., Frank Z.R. Mycotoxigenic potential of Aspergillus flavus strains isolated from groundnut growing in Israel. Mycopathologia 1993, 122:177-183.
33. Liu Y., Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environmental Health Perspectives 2010, 118:818-824.
34. Maurya R. Chemistry and pharmacology of Withania coagulans: an Ayurvedic remedy. Journal of Pharmacy and Pharmacology 2010, 62:153-160.
35. Milita N.M., Mihaescu G., Chifiriuc C. Aflatoxins-health risk factors. Bacteriologia Virusologia Parazitologia Epidemiologia 2010, 55:19-24.
36. Mogra R., Dashora V. Exploring the use of Stevia rebaudiana as a sweetener in comparison with other sweeteners. Journal of Human Ecology 2009, 25:117-120.
37. Muñoz K., Vega M., Rios G., Geisen R., Degen G.H. Mycotoxin production by different ochratoxigenic Aspergillus and Penicillium species on coffee- and wheat-based media. Mycotoxin Research 2011, 27:239-247.
38. Nandal U., Bhardwaj R.L. Aloe vera for human nutrition, health and cosmetic use - a review. International Research Journal of Plant Sciences 2012, 3:38-46.
39. Newall C.A., Anderson L.A., Phillipson J.D. Herbal Medicines: a guide for health-care professionals 1996, Pharmaceutical Press, London.
40. Nithiyaa P., Nur Ain Izzati M.Z., Umi Kalsom Y., Salleh B. Diversity and morphological characteristics of Aspergillus species and Fusarium species isolated from cornmeal in Malaysia. Pertanika Journal of Tropical Agricultural Science 2012, 35:103-116.
41. Petzinger E., Ziegler K. Ochratoxin A from a toxicological perspective. Journal of Veterinary Pharmacology and Therapeutics 2000, 23:91-98.
42. Prakash P., Gupta N. Therapeutic uses of Ocimum Sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review. Indian Journal of Physiology and Pharmacology 2005, 49:125-131.
43. Rizzo I., Vedoya G., Maurutto S., Haidukowski M., Varsavsky E. Assessment of toxigenic fungi on Argentinean medicinal herbs. Microbiological Research 2004, 159:113-120.
44. Romagnoli B., Menna V., Gruppioni N., Bergamini C. Aflatoxins in spices, aromatic herbs, herb-teas and medicinal plants marketed in Italy. Food Control 2007, 18:697-701.
45. Roy A.K., Chourasia H.K. Mycoflora, mycotoxin producibility and mycotoxins in traditional herbal drugs from India. Journal of General and Applied Microbiology 1990, 36:295-302.
46. Roy A.K., Sinha K.K., Chourasia H.K. Aflatoxin contamination of some common drug plants. Applied and Environmental Microbiology 1988, 54:842-843.
47. Santos L., Marin S., Sanchis V., Ramos A.J. Screening of mycotoxin multicontamination in medicinal and aromatic herbs sampled in Spain. Journal of the Science of Food and Agriculture 2009, 89:1802-1807.
48. Scott P.M. Effects of food processing on mycotoxins. Journal of Food Protection 1984, 47:489-499.
49. Scott P.M. Natural poisons. Official Methods of Analysis of the Association of Official Analytical Chemists 1990, Association of Official Analytical Chemists, Arlington, Virginia, p.1197. 16th edn. K. Helrich (Ed.).
50. Sedmikova M., Reisnerora H., Dufkova Z., Burta I., Jilek F. Potential hazard of simultaneous occurrence of aflatoxin B1 and ochratoxin A. Veterinary Medicine 2001, 46:169-174.
51. Shah G., Shri R., Panchal V., Sharma N., Singh B., Mann A.S. Scientific basis for the therapeutic use of Cymbopogon citratus, stapf (Lemon grass). Journal of Advanced Pharmaceutical Technology & Research 2011, 2:3-8.
52. Shinwari Z.K. Medicinal plants research in Pakistan. Journal of Medicinal Plants Research 2010, 4:161-176.
53. Speijers G.J., Speijers M.H. Combined toxic effects of mycotoxins. Toxicology Letters 2004, 153:91-98.
54. Steel R.D., Torrie J.H., Dickey D. Principles and Procedures of Statistic. A Biometrical Approach 1997, McGraw Hills Book Co. Inc, New York. 3rd edn.
55. Tassaneeyakul W., Razzazi-Fazeli E., Porasuphatana S., Bohm J. Contamination of aflatoxins in herbal medicinal products in Thailand. Mycopathologia 2004, 158:239-244.
56. Trucksess M., Weaver C., Oles C., D'Ovidio K., Rader J. Determination of aflatoxins and ochratoxin A in ginseng and other botanical roots by immunoaffinity column cleanup and liquid chromatography with fluorescence detection. Journal of AOAC International 2006, 89:624-630.
57. United States Pharmacopeia 28-National Formulary 23 (USP 28/NF 23) United States Pharmacopeial Convention Inc. 2005, Rockville, MD.
58. Wainstein J., Ganz T., Boaz M., Dayan Y.B., Dolev E., Kerem Z., Madar Z. Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. Journal of Medicinal Food 2012, 15:605-610.
59. Waskiewicz A., Beszterda M., Bocianowski J., Golinski P. Natural occurrence of fumonisins and ochratoxin A in some herbs and spices commercialized in Poland analyzed by UPLCeMS/MS method. Food Microbiology 2013, 36:426-431.
60. Yang L., Wang L., Pan J., Xiang L., Yang M., Logrieco A.F. Determination of ochratoxin A in traditional Chinese medicinal plants by HPLC-FLD. Food Additives & Contaminants: Part A 2010, 27:989-997.